For the quarter ending 2025-09-30, LPTX has $11,399K in assets. $8,704K in debts. $9,686K in cash and cash equivalents.
| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 9,686 | 18,130 | ||
| Research and development incentive receivable | 743 | 739 | ||
| Prepaid expenses and other current assets | 69 | 292 | ||
| Total current assets | 10,498 | 19,161 | ||
| Right of use assets, net | 38 | 38 | ||
| Deferred costs | 80 | - | ||
| Deposits | 783 | 784 | ||
| Research and development incentive receivable, net of current portion | - | 59 | ||
| Total assets | 11,399 | 20,042 | ||
| Accounts payable | 4,279 | 7,339 | ||
| Accrued expenses | 3,860 | 6,623 | ||
| Income tax payable | 527 | 324 | ||
| Lease liability | 38 | 39 | ||
| Total current liabilities | 8,704 | 14,325 | ||
| Total liabilities | 8,704 | - | ||
| Common stock, 0.001 par value 240,000,000 shares authorized 41,439,529 and 38,329,894 shares issued and outstanding as of september 30, 2025 and december 31, 2024, respectively | 41 | 41 | ||
| Additional paid-in capital | 505,510 | 505,207 | ||
| Accumulated other comprehensive loss | -104 | -82 | ||
| Accumulated deficit | -502,752 | -499,449 | ||
| Total stockholders' equity | 2,695 | 5,717 | ||
| Total liabilities and stockholders' equity | 11,399 | 20,042 | ||
LEAP THERAPEUTICS, INC. (LPTX)
LEAP THERAPEUTICS, INC. (LPTX)